Molecular complete remission following combination treatment of daratumumab and venetoclax in an adolescent with relapsed mixed phenotype acute leukemia

Martin Stanulla(Leibniz University Hannover), Britta Maecker‐Kolhoff(Medizinische Hochschule Hannover), Beat Bornhäuser(University Children's Hospital Zurich), Denis M. Schewe(Klinik und Poliklinik für Kinder- und Jugendmedizin), Julian Wolf(Palo Alto University), Gunnar Cario, Jean‐Pierre Bourquin(University Children's Hospital Zurich), Martin G. Sauer, Saskia Wolf(Otto-von-Guericke-Universität Magdeburg), Christian P. Kratz(Medizinische Hochschule Hannover), Fotini Vogiatzi(Christian-Albrechts-Universität zu Kiel), Cornelia Eckert(Humboldt-Universität zu Berlin), Rita Beier(Medizinische Hochschule Hannover), Anke K. Bergmann(Medizinische Hochschule Hannover), W. Eberl(Klinikum Braunschweig)
Annals of Hematology
January 18, 2023
10.1007/s00277-023-05083-y
Cited by 7

Related Papers

Comprehensive Analysis of Hypermutation in Human Cancer
|Cell|2017|795
Clinical and molecular diagnosis, screening and management of Beckwith–Wiedemann syndrome: an international consensus statement
|Nature Reviews Endocrinology|2018|596
Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group
|Blood|2009|347
A restricted spectrum of NRAS mutations causes Noonan syndrome
|Nature Genetics|2009|317
Induction of autophagy-dependent necroptosis is required for childhood acute lymphoblastic leukemia cells to overcome glucocorticoid resistance
|Journal of Clinical Investigation|2010|311